Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-503 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement. EDIC is an observational study that was launched at the completion of the Diabetes Control and Complications Trial (DCCT) trial. The DCCT showed that intensive therapy significantly reduced the risk of diabetes complications compared to conventional therapy. At DCCT completion, all cohort members were taught intensive diabetes therapy. In 1...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 17, 2021 Category: Research Source Type: funding
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites a single cooperative agreement application to establish a biorepository of human cardiovascular (CV) tissue and an infrastructure for discovery and mechanistic research to increase our knowledge of the CV complications of type 1 diabetes (T1D). Cardiovascular disease (CVD) is the leading cause of death and morbidity for individuals with T1D, but no T1D-specific therapy exists to prevent or treat this complication of diabetes because of challenges from inadequate preclinical models, decades-l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 4, 2021 Category: Research Source Type: funding
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-22-011 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds , including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 26, 2021 Category: Research Source Type: funding
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
Funding Opportunity RFA-HL-22-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of highly trained investigators from diverse backgrounds, including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 25, 2021 Category: Research Source Type: funding
Decoding Disparities QuickFire Challenge
A challenge seeking innovative ideas to better understand health disparities in the areas of mental health, inflammatory bowel diseases, and cardiovascular disease. Populations of interest include racial and ethnic minority populations, as well as the rural and urban poor. Geographic coverage: Nationwide -- Janssen Scientific Affairs, LLC, Johnson and Johnson Innovation (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 11, 2021 Category: American Health Source Type: funding
Availability of Frequently Asked Questions (FAQs) for RFA-HL-22-007 and RFA-HL-22-008: Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) program
Notice NOT-HL-21-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 11, 2021 Category: Research Source Type: funding
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-22-001 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to enhance the participation of individuals from nationally underrepresented backgrounds in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity. The NHLBI's T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and indivi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 11, 2021 Category: Research Source Type: funding
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required)
Funding Opportunity RFA-HL-22-008 from the NIH Guide for Grants and Contracts. This FOA runs in parallel with the companion FOA (RFA-HL-22-007). This FOA uses the bi-phasic, milestone-driven UG3/UH3 cooperative agreement mechanism (UG3/UH3), and runs in parallel with a companion FOA (RFA-HL-22-008), which seeks applications for a Data Coordinating Center (DCC). Awards made under this FOA will support a milestone-driven planning phase, including feasibility studies and pilot trials for up to 2 years, with possible transition to an implementation phase (UH3) for up to five additional years. Only UG3 trials that meet the s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 22, 2021 Category: Research Source Type: funding
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-HL-22-007 from the NIH Guide for Grants and Contracts. This FOA uses the bi-phasic, milestone-driven UG3/UH3 cooperative agreement mechanism (UG3/UH3), and runs in parallel with a companion FOA (RFA-HL-22-008), which seeks applications for a Data Coordinating Center (DCC). Awards made under this FOA will support a milestone-driven planning phase, including feasibility studies and pilot trials for up to 2 years, with possible transition to an implementation phase (UH3) for up to five additional years. Only UG3 trials that meet the scientific milestones and award requirements of the UG3 phase may t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 22, 2021 Category: Research Source Type: funding
Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional)
Funding Opportunity RFA-HL-21-014 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity is to support research that enhances the understanding of the pathophysiology and epidemiology of cardiovascular disease (CVD) among individuals with Type 1 Diabetes Mellitus (T1DM), and support the development of interventions to reduce CVD risk among these individuals. The overall goal is to develop evidence-based guidelines to prevent or reduce CVD complications of T1DM across the lifespan. This funding opportunity will support epidemiologic studies to refine risk assessment, mechanistic studies to enha...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 6, 2021 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite (UG3/UH3) with Coordinating Center (U24)
Notice NOT-HL-20-820 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 27, 2020 Category: Research Source Type: funding
RESolution of InflammaTion in EnvirOnmentally Related diseasE (RESTORE) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-013 from the NIH Guide for Grants and Contracts. The purpose of the RESTORE program is to advance understanding of the role of inflammation resolution pathways at the cellular and molecular level and how exposure to environmental pollutants interferes with these pathways resulting in exposure-induced chronic systemic inflammation and ultimately chronic disease conditions. The initial phase of this program is focused on understanding how chronic exposure to air pollution interferes with resolution of inflammation in pulmonary, cardiovascular, and metabolic systems and diseases. (Source: NIH ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2020 Category: Research Source Type: funding
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
Funding Opportunity RFA-DK-20-011 from the NIH Guide for Grants and Contracts. Acute kidney injury (AKI) is associated with high morbidity, including increased risk of chronic kidney disease (CKD), end-stage kidney disease (ESKD), cardiovascular disease, and mortality. Severity, duration, and frequency of episodes of AKI as well as age, pre-existing CKD, and other comorbidities are associated with greater risks of CKD progression and death. There is limited evidence to inform recommendations for processes of care or therapeutic interventions targeting progression of kidney disease and the associated morbidity and mortal...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 7, 2020 Category: Research Source Type: funding
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
Funding Opportunity RFA-DK-20-012 from the NIH Guide for Grants and Contracts. Acute kidney injury (AKI) is associated with high morbidity, including increased risk of chronic kidney disease (CKD), end-stage kidney disease (ESKD), cardiovascular disease, and mortality. Severity, duration, and frequency of episodes of AKI as well as age, pre-existing CKD, and other comorbidities are associated with greater risks of CKD progression and death. There is limited evidence to inform recommendations for processes of care or therapeutic interventions targeting progression of kidney disease and the associated morbidity and mortal...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 7, 2020 Category: Research Source Type: funding
Supporting Primary Care to Advance Cardiovascular Health in States with High Prevalence of Preventable CVD Events (U18)
Funding to develop sustainable, quality improvement support capacity through partnership with state and local organizations, build and engage a network of primary care practices, disseminate research findings on heart health, and increase the capacity of primary care practices to implement evidence in the future. Primary care may include non-traditional sources of primary care services such as public health clinics, rural hospitals, work-based clinics, and migrant clinics. Geographic coverage: Nationwide -- Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (Source: Funding opportuniti...
Source: Funding opportunities via the Rural Health Information Hub - March 20, 2020 Category: American Health Source Type: funding
